Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ: NTRA )

155.59 -1.02 (-0.65%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 28, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,860,496
Open 159.94
Bid (Size) 150.00 (1)
Ask (Size) 158.00 (3)
Prev. Close 156.61
Today's Range 150.00 - 165.00
52wk Range 83.13 - 183.00
Shares Outstanding 135,186,184
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Deep Dive Into Natera Stock: Analyst Perspectives (9 Ratings)
Via Benzinga
Natera (NASDAQ:NTRA) Reports Bullish Q4, Guides for Strong Full-Year Sales
Genetic testing company Natera (NASDAQ:NTRA). reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 53% year on year to $476.1 million. The company’s full-year revenue... 
Via StockStory

Performance

YTD
-3.12%
-3.12%
1 Month
-11.73%
-11.73%
3 Month
-8.38%
-8.38%
6 Month
+36.51%
+36.51%
1 Year
+74.02%
+74.02%

More News

Read More
Natera Reports Fourth Quarter and Full Year 2024 Financial Results
From Natera, Inc.
Via Business Wire
Earnings Scheduled For February 27, 2025
Via Benzinga
Natera (NTRA) Q4 Earnings: What To Expect
Via StockStory
Natera Announces Medicare Coverage of Signatera™ for Surveillance in Lung Cancer
From Natera, Inc.
Via Business Wire
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Natera to Report its Fourth Quarter and Full Year Results on February 27, 2025
From Natera, Inc.
Via Business Wire
Billionaire Investor Stanley Druckenmiller Dumps Broadcom, Bets Big On Tesla, Amazon And Other Big Tech Stocks In Q4
Via Benzinga
NATERA INC is setting up nicely for a breakout.
Via Chartmill
Why NATERA INC (NASDAQ:NTRA) qualifies as a high growth stock.
Via Chartmill
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
Via Chartmill
Looking Into Natera's Recent Short Interest
Via Benzinga
The S&P 500 Fights Through Challenging Headlines To Close At New Weekly All-Time Highs
Via Talk Markets
Topics Stocks Stocks / Equities
Exposures US Equities
NCCN Strengthens Guidance on ctDNA in Colon Cancer, Rectal Cancer, and Merkel Cell Carcinoma
From Natera, Inc.
Via Business Wire
Natera Announces National Commercial Coverage for its Fetal RhD NIPT
From Natera, Inc.
Via Business Wire
Small- To Mid-Cap Biotech Trades Poised For Gains
Via Talk Markets
Topics ETFs Stocks / Equities
Natera Announces Successful Readout of Randomized, Phase III CALGB (Alliance) / SWOG 80702 Clinical Trial in Colorectal Cancer
From Natera, Inc.
Via Business Wire
Natera to Present New Data at the 2025 ASCO GI Symposium
From Natera, Inc.
Via Business Wire
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
Via Investor's Business Daily
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Via Benzinga
The End Of The 60/40 Portfolio
Via Benzinga
Topics Bonds
Exposures Debt Markets
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Natera CEO Steve Chapman Recognized as a 2024 Top Healthcare Technology CEO and BioTechnology Innovator of the Year
From Natera, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.